Right Handed Weak Currents in Sum Rules for Axialvector Constant Renormalization

The recent experimental results on deep inelastic polarized lepton scattering off proton, deuteron and $^{3}$He together with polari% zed neutron $\beta$-decay data are analyzed. It is shown that the problem of Ellis-Jaffe and Bjorken sum rules deficiency and the neutron paradox could be solved simultaneously by assuming the small right handed current (RHC) admixture in the weak interaction Lagrangian. The possible RHC impact on pion-nucleon $\sigma$-term and Gamow-Teller sum rule for $(p,n)$ nuclear reactions is pointed out.Comment: to be published in Phys. Rev. Lett. LaTeX, 8 pages, 21 k

Non-Waste Alternative Technologies in the Production of Heterologous Anti-Rabies Immunoglobulin

Presented is a comprehensive approach to utilization of the wastes that appear in the process of heterologous anti-rabies immunoglobulin production (packed red cells, fibrin, and alcohol-containing products). Specific immunoglobulin is extracted from the surface of red blood cells using desorption technique. Additional yields of immunoglobulin after exposure of erythrocytes to non-ionic detergent amount to 10-19 % of the output. Rich protein supplement feeding for horses-producers is obtained from spray-dried packed red cells. Solid nutritious substrate for microbiological media production is obtained from fibrin using enzymic hydrolysis method. The efficiency of the fibrin hydrolysate-based media is 1.5-2 times higher in comparison with that of the media based on the digest of meat and casein, as demonstrated by the results of Vibrio cholerae scaled cultivation. Furthermore, worked out is the technology of ethanol regeneration after the rivanol-ethanolic precipitation of gamma globulin, alcohol content by volume being (93±1) % after the regeneration. It is demonstrated that the regenerated alcohol can be used as a precipitator in the process of anti-rabies serum fractioning. All in all, the developed techniques make it possible to utilize the wastes of anti-rabies immunoglobulin production and provide for further use of derivatives while producing medical immunobiological preparations